Eisai
4523.T
#2142
Rank
โ‚ฌ8.04 B
Marketcap
28,51ย โ‚ฌ
Share price
-0.42%
Change (1 day)
10.97%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): 0,78ย โ‚ฌ

According to Eisai's latest financial reports the company's current EPS (TTM) is 0,78ย โ‚ฌ. In 2026 the company made an earnings per share (EPS) of 0,77ย โ‚ฌ a decrease over its 2025 EPS that were of 0,98ย โ‚ฌ.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
20260,77ย โ‚ฌ-21.04%
20250,98ย โ‚ฌ11.85%
20240,87ย โ‚ฌ-32.63%
20231,30ย โ‚ฌ5.52%
20221,23ย โ‚ฌ-74.01%
20214,73ย โ‚ฌ-66.58%
202014,17ย โ‚ฌ98.24%
20197,15ย โ‚ฌ17.01%
20186,11ย โ‚ฌ37.78%
20174,43ย โ‚ฌ-27.62%
20166,12ย โ‚ฌ35.33%
20154,53ย โ‚ฌ-2.82%
20144,66ย โ‚ฌ-27.66%
20136,44ย โ‚ฌ-27.49%
20128,88ย โ‚ฌ-12.67%
201110,17ย โ‚ฌ88.08%
20105,41ย โ‚ฌ-11.06%
20096,08ย โ‚ฌ-390.15%
2008-2,09ย โ‚ฌ-127.78%
20077,54ย โ‚ฌ347.11%
20061,69ย โ‚ฌ4.38%
20051,62ย โ‚ฌ7.4%
20041,50ย โ‚ฌ43.03%
20031,05ย โ‚ฌ25.09%
20020,84ย โ‚ฌ52.67%
20010,55ย โ‚ฌ69.76%
20000,32ย โ‚ฌ